Pharma Intelligence відкриті
[search 0]
більше

Download the App!

show episodes
 
Deep Pharma Intelligence (DPI) is a leading strategic and investment intelligence agency focused on the emerging markets in the Pharmaceutical, BioTech, and Healthcare Tech industries. DPI is producing regular analytical reports on major areas of high-potential in the pharmaceutical and healthcare industries, maintaining ratings of companies and governments based on their innovation potential and business activity in the BioTech space, and providing strategic consulting and investment intell ...
 
Loading …
show series
 
Pink Sheet reporters and editors discuss the newly approved ALS drug Relvyrio, the promising data on the Alzheimer’s drug lecanemab, and CMS’s efforts to build the drug price negotiation programInforma
 
In the second episode featuring highlights from a recent panel on mRNA manufacturing, experts from BioNTech, Sanofi, eTheRNA, IAVI and TriLink Biotechnologies will discuss the role of stability, CDMO partnerships, emerging mRNA platforms and the importance of locking these down early.Informa
 
Following the global pandemic and success of mRNA technology in vaccines immunizing against severe COVID-19 infections, a panel of experts from BioNTech, Sanofi, eTheRNA, IAVI and TriLink Biotechnologies came together to discuss how industry can ease the bottlenecks that currently exist to wider usage of mRNA. The first of two podcast episodes feat…
 
Post-ESMO report:https://www.biomedtracker.com/reportdetail.cfm?reportid=1686Other platforms:Apple Podcasts -   podcasts.apple.com/us/podcast/phar…sts/id923189836Google Podcasts - podcasts.google.com/feed/aHR0cHM6Ly…C9zb3VuZHMucnNzTuneIn - tunein.com/podcasts/Business--…-Podcasts-p1140128/Spotify Podcasts - open.spotify.com/show/3DTc3eIh4xI6pVOd6Dd…
 
Pink Sheet reporters and editor discuss the impact of the long wait for a user fee deal to be negotiated, how the FDA will interpret President Biden’s declaration that the COVID-19 pandemic is over, and concerns with the clinical development of the monkeypox treatment Tpoxx.Informa
 
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。For listeners in pharma industry, we deliver a summarized insight from Scrip and Pink Sheet in Japanese, one story at a time.今回取り上げた記事はこちらThe selected article for this episode is:Bharat Biotech Debuts World’s First Exclusively Intranasal COVID-19 …
 
Pink Sheet reporters and editors discuss the role of real world evidence in US FDA product decisions, staffing and other problems that are limiting the agency’s ability to implement lessons from the pandemic, and updates to COVID-19 vaccine adverse event reporting requirements.Informa
 
In this month’s Digital Health Roundup, Medtech Insight’s Reed Miller talks about Biotronik’s and AliveCor’s partnership, Marion Webb profiles three agetech companies, and Barnaby Pickering talks Swiss medtech awards and smart hospitals.Listen to the podcast via the player below: Medtech Insight articles addressing topics discussed in this episode:…
 
중국 의약품 관련 미국의 규제 환경과 이로 인한 영향은 무엇인 지 베이진의 연구개발 총괄 라이 왕 박사의 Pink Sheet 인터뷰 기사를 요약한 내용입니다.https://pink.pharmaintelligence.informa.com/PS146934/BeiGene-Head-of-RD-Lai-Wang-On-Going-GlobalInforma
 
Pink Sheet reporters and editors discuss the positive advisory committee recommendation for Amylyx’s proposed ALS treatment, the striking drop in clinical trials conducted in Russia following the start of the war in Ukraine, and questions about Medicare price negotiations avoiding political influence.…
 
In this new series titled Getting Personal, we talk to new and veteran executives about the trials and tribulations in running a company while exploring their own motivations and passions. In this first edition, we talk to Sidney Collin, co-founder and CEO of De Oro Devices. Collin invented NexStride, a portable device to help overcome freezing of …
 
• What are the benefits of the decentralized clinical trial (DCT) model?• What are the barriers to sites and investigators participating in DCTs?• What support measures are critical to DCT success?• What is the outlook for DCTs during the coming 3 – 5 years and how can sites and investigators contribute to their evolution?Listen to a lively discuss…
 
Loading …

Короткий довідник

Google login Twitter login Classic login